(Q33316357)

25 July 2017

title

Proteasome inhibition suppresses essential immune functions of human CD4+ T cells (English)

1 reference

25 July 2017

6

Gerhard Opelz

1 reference

25 July 2017

5

Mahmoud Sadeghi

1 reference

25 July 2017

Carsten Berges

1

1 reference

25 July 2017

Heinrich Haberstock

2

1 reference

25 July 2017

Dominik Fuchs

3

1 reference

25 July 2017

Marion Miltz

4

1 reference

25 July 2017

Volker Daniel

7

1 reference

25 July 2017

Cord Naujokat

8

1 reference

25 July 2017

publication date

23 January 2008

1 reference

25 July 2017

1 reference

25 July 2017

volume

124

1 reference

25 July 2017

issue

2

1 reference

25 July 2017

page(s)

234-246

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02761.X

25 July 2017

1 reference

The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02761.X

The proteasome: paradigm of a self-compartmentalizing protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02761.X

The 26S proteasome: a molecular machine designed for controlled proteolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02761.X

Antigen processing by the proteasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02761.X

Contribution of proteasomal beta-subunits to the cleavage of peptide substrates analyzed with yeast mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02761.X

Inhibitors of the eukaryotic 20S proteasome core particle: a structural approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02761.X

Development of the proteasome inhibitor Velcade (Bortezomib).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02761.X

Adaptive modification and flexibility of the proteasome system in response to proteasome inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02761.X

Activation of the cell death program by inhibition of proteasome function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02761.X

Proteasome inhibitors induced caspase-dependent apoptosis and accumulation of p21WAF1/Cip1 in human immature leukemic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02761.X

Proteasome inhibition as a novel therapeutic target in human cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02761.X

The proteasome and proteasome inhibitors in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02761.X

Proteasome inhibitor bortezomib modulates TLR4-induced dendritic cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02761.X

Proteasomal chymotrypsin-like peptidase activity is required for essential functions of human monocyte-derived dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02761.X

Role of the proteasome and NF-kappaB in streptococcal cell wall-induced polyarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02761.X

A proteasome inhibitor effectively prevents mouse heart allograft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02761.X

Inhibition of acute graft-versus-host disease with retention of graft-versus-tumor effects by the proteasome inhibitor bortezomib

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02761.X

Dipeptide boronic acid, a novel proteasome inhibitor, prevents islet-allograft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02761.X

Use of systemic proteasome inhibition as an immune-modulating agent in disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02761.X

Cell cycle- and activation-dependent regulation of cyclosporin A-induced T cell apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02761.X

Bortezomib induces selective depletion of alloreactive T lymphocytes and decreases the production of Th1 cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02761.X

Extended peptide-based inhibitors efficiently target the proteasome and reveal overlapping specificities of the catalytic beta-subunits

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02761.X

Activity probe for in vivo profiling of the specificity of proteasome inhibitor bortezomib

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02761.X

Caspase-3-dependent Apoptosis in Vascular Smooth Muscle Cell by Proteasome Inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02761.X

p53 mediates nontranscriptional cell death in dopaminergic cells in response to proteasome inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02761.X

Apoptosis induced by proteasome inhibition in cancer cells: predominant role of the p53/PUMA pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02761.X

Ubiquitin-mediated proteolysis of vertebrate G1- and S-phase regulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02761.X

Lovastatin-mediated G1 arrest is through inhibition of the proteasome, independent of hydroxymethyl glutaryl-CoA reductase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02761.X

Induction of G1 arrest and apoptosis in human jurkat T cells by pentagalloylglucose through inhibiting proteasome activity and elevating p27Kip1, p21Cip1/WAF1, and Bax proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02761.X

Baohuoside-1 inhibits activated T cell proliferation at G(1)-S phase transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02761.X

Transcription factors of the NFAT family: regulation and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02761.X

The interleukin 2 receptor alpha chain/CD25 promoter is a target for nuclear factor of activated T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02761.X

B lymphocyte activation during cognate interactions with CD4+ T lymphocytes: molecular dynamics and immunologic consequences.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02761.X

Cooperation between CD4+ and CD8+ T cells: when, where, and how.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02761.X

p53-dependent cell cycle arrest induced by N-acetyl-L-leucinyl-L-leucinyl-L-norleucinal in platelet-derived growth factor-stimulated human fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02761.X

Proteasome-dependent regulation of p21WAF1/CIP1 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02761.X

Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02761.X

p45SKP2 promotes p27Kip1 degradation and induces S phase in quiescent cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02761.X

Growth suppression induced by wild-type p53 protein is accompanied by selective down-regulation of proliferating-cell nuclear antigen expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02761.X

The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02761.X

NFAT proteins: key regulators of T-cell development and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02761.X

Transcriptional regulation by calcium, calcineurin, and NFAT

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02761.X

The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02761.X

Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin-proteasome pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02761.X

The ubiquitin proteolytic system: from a vague idea, through basic mechanisms, and onto human diseases and drug targeting

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2566628

Proteasome inhibitors as therapeutics

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2566628

Small-molecule inhibitors of proteasome activity

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2566628

Role and function of the 26S proteasome in proliferation and apoptosis.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2566628

Proteasome inhibition reduces superantigen-mediated T cell activation and the severity of psoriasis in a SCID-hu model

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2566628

Cells adapted to the proteasome inhibitor 4-hydroxy- 5-iodo-3-nitrophenylacetyl-Leu-Leu-leucinal-vinyl sulfone require enzymatically active proteasomes for continued survival

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2566628

Calcineurin: form and function

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2566628

Induction of G1 arrest and selective growth inhibition by lactacystin in human umbilical vein endothelial cells.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2566628

CD4+ T cells orchestrate both amplification and deletion of CD8+ T cells.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2566628

p21 is necessary for the p53-mediated G1 arrest in human cancer cells

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2566628

Proliferating cell nuclear antigen (PCNA)/cyclin in activated human T lymphocytes.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2566628

Cell-cycle inhibition by independent CDK and PCNA binding domains in p21Cip1

31 October 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02761.X

Transcription factor E2F controls the reversible gamma delta T cell growth arrest mediated through WC1

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2566628

Role of p53 in cell cycle regulation and apoptosis following exposure to proteasome inhibitors

10 December 2018

1 reference

12 December 2020

Human THP-1 monocytic leukemic cells induced to undergo monocytic differentiation by bryostatin 1 are refractory to proteasome inhibitor-induced apoptosis

1 reference

12 December 2020

Inhibition of cellular proliferation by antisense oligodeoxynucleotides to PCNA cyclin

1 reference

12 December 2020

WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis

1 reference

12 December 2020

Downregulation of PCNA potentiates p21-mediated growth inhibition in response to hyperoxia

1 reference

12 December 2020

In vivo ubiquitination and proteasome-mediated degradation of p53(1)

1 reference

12 December 2020

p53-dependent induction of apoptosis by proteasome inhibitors

1 reference

12 December 2020

p21 binding to PCNA causes G1 and G2 cell cycle arrest in p53-deficient cells

1 reference

12 December 2020

Effects of guanine nucleotide depletion on cell cycle progression in human T lymphocytes

1 reference

12 December 2020

Interaction with cyclin-dependent kinases and PCNA modulates proteasome-dependent degradation of p21

1 reference

12 December 2020

Proteasome active sites allosterically regulate each other, suggesting a cyclical bite-chew mechanism for protein breakdown

1 reference

12 December 2020

10.1111/J.1365-2567.2007.02761.X

Identifiers

DOI

1 reference

25 July 2017

0 references

1 reference